Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1990 Feb 10;300(6721):344–345. doi: 10.1136/bmj.300.6721.344

Stopping steroids in polymyalgia rheumatica and giant cell arteritis.

V Kyle 1, B L Hazelman 1
PMCID: PMC1662131  PMID: 2106980

Full text

PDF
345

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayoub W. T., Franklin C. M., Torretti D. Polymyalgia rheumatica. Duration of therapy and long-term outcome. Am J Med. 1985 Sep;79(3):309–315. doi: 10.1016/0002-9343(85)90309-2. [DOI] [PubMed] [Google Scholar]
  2. BAGRATUNI L. Prognosis in the anarthritic rheumatoid syndrome. Br Med J. 1963 Feb 23;1(5329):513–518. doi: 10.1136/bmj.1.5329.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BARBER H. S. Myalgic syndrome with constitutional effects; polymyalgia rheumatica. Ann Rheum Dis. 1957 Jun;16(2):230–237. doi: 10.1136/ard.16.2.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BIRKHEAD N. C., WAGENER H. P., SHICK R. M. Treatment of temporal arteritis with adrenal corticosteroids; results in fifty-five cases in which lesion was proved at biopsy. J Am Med Assoc. 1957 Mar 9;163(10):821–827. doi: 10.1001/jama.1957.02970450023007. [DOI] [PubMed] [Google Scholar]
  5. Behn A. R., Perera T., Myles A. B. Polymyalgia rheumatica and corticosteroids: how much for how long? Ann Rheum Dis. 1983 Aug;42(4):374–378. doi: 10.1136/ard.42.4.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Benlahrache C., Segond P., Auquier L., Bouvet J. P. Decrease of the OKT8 positive T cell subset in polymyalgia rheumatica. Lack of correlation with disease activity. Arthritis Rheum. 1983 Dec;26(12):1472–1480. doi: 10.1002/art.1780261209. [DOI] [PubMed] [Google Scholar]
  7. Chuang T. Y., Hunder G. G., Ilstrup D. M., Kurland L. T. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982 Nov;97(5):672–680. doi: 10.7326/0003-4819-97-5-672. [DOI] [PubMed] [Google Scholar]
  8. Coomes E. N., Ellis R. M., Kay A. G. A prospective study of 102 patients with the polymyalgia rheumatica syndrome. Rheumatol Rehabil. 1976 Nov;15(4):270–279. doi: 10.1093/rheumatology/15.4.270. [DOI] [PubMed] [Google Scholar]
  9. Dasgupta B., Duke O., Timms A. M., Pitzalis C., Panayi G. S. Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis. 1989 Apr;48(4):307–311. doi: 10.1136/ard.48.4.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. De Silva M., Hazleman B. L. Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis. 1986 Feb;45(2):136–138. doi: 10.1136/ard.45.2.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Delecoeuillerie G., Joly P., Cohen de Lara A., Paolaggi J. B. Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients). Ann Rheum Dis. 1988 Sep;47(9):733–739. doi: 10.1136/ard.47.9.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Elling H., Elling P. Decreased level of suppressor/cytotoxic T cells (OKT8+) in polymyalgia rheumatica and temporal arteritis: relation to disease activity. J Rheumatol. 1985 Apr;12(2):306–309. [PubMed] [Google Scholar]
  13. Fainaru M., Friedman G., Friedman B. Temporal arteritis in Israel. A review of 47 patients. J Rheumatol. 1979 May-Jun;6(3):330–335. [PubMed] [Google Scholar]
  14. Fauchald P., Rygvold O., Oystese B. Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings. Ann Intern Med. 1972 Dec;77(6):845–852. doi: 10.7326/0003-4819-77-6-845. [DOI] [PubMed] [Google Scholar]
  15. Graham E., Holland A., Avery A., Russell R. W. Prognosis in giant-cell arteritis. Br Med J (Clin Res Ed) 1981 Jan 24;282(6260):269–271. doi: 10.1136/bmj.282.6260.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Huston K. A., Hunder G. G. Giant cell (cranial) arteritis: a clinical review. Am Heart J. 1980 Jul;100(1):99–105. doi: 10.1016/0002-8703(80)90285-9. [DOI] [PubMed] [Google Scholar]
  17. Jones J. G., Hazleman B. L. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis. 1981 Feb;40(1):1–5. doi: 10.1136/ard.40.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kyle V., Hazleman B. L. Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects. Ann Rheum Dis. 1989 Aug;48(8):662–666. doi: 10.1136/ard.48.8.662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Myles A. B. Polymyalgia rheumatica and giant cell arteritis: a seven-year survey. Rheumatol Rehabil. 1975 Nov;14(4):231–235. doi: 10.1093/rheumatology/14.4.231. [DOI] [PubMed] [Google Scholar]
  20. Spiera H., Davison S. Treatment of polymyalgia rheumatica. Arthritis Rheum. 1982 Jan;25(1):120–120. doi: 10.1002/art.1780250124. [DOI] [PubMed] [Google Scholar]
  21. Vilaseca J., González A., Cid M. C., Lopez-Vivancos J., Ortega A. Clinical usefulness of temporal artery biopsy. Ann Rheum Dis. 1987 Apr;46(4):282–285. doi: 10.1136/ard.46.4.282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. von Knorring J. Treatment and prognosis in polymyalgia rheumatica and temporal arteritis. A ten-year survey of 53 patients. Acta Med Scand. 1979;205(5):429–435. doi: 10.1111/j.0954-6820.1979.tb06077.x. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES